Access Menu

Log in via Social

Log in with LinkedIn
CANNABINOID BIOSCIENCES, INC.

CANNABINOID BIOSCIENCES, INC.

Opportunity to get in on the ground floor of CBD investment, with CBDZ Secured Convertible 8% Notes offered under Reg. D 506 (c).

Verify Investor Status to make a reservation

Company Overview

Cannabinoid Biosciences, Inc. ("CBDZ") is a biopharmaceutical company, which intends to engage in the discovery, development and commercialization of cures and novel therapeutics from proprietary cannabinoid, cannabidiol, endocannabinoids, phytocannabinoids, and synthetic cannabinoids product platform suitable for specific treatments in a broad range of disease areas.

CBDZ's mission is to revolutionize and standardize the pharmaceuticals and non-pharmaceutical CBD products formulation across the CBD market in the United States of America and to some extent, globally. CBDZ seeks to control the production and distribution of verities of consumer cannabidiol (CBD) formulation under private brands in the United States. CBDZ’s goal is to bring standardization to the CBD industry, the same way that John D Rockefeller’s Standard Oil brought standardization to crude refining in the United States in the nineteenth century. CBDZ’s product lineup would include tinctures, capsules, gummies, bath bombs, vape oils, topical creams, and animal treats and oils. CBDZ is currently developing two marketplaces for CDB, namely www.Cannabidiolhemp.net and www.Cbdhempextra.com. Once they are both up and running, the company intends to sell its products directly to consumers through the marketplaces, company Website, as well as through non-affiliated stores.

The company was founded in 2014 and is based in Los Angeles, California. https://cbdxfund.com/invest/

The company intends to engaged in the following areas of the legal CBD business: (1) Ownership interest in certain businesses that extract, purchase and distribute Bulk Pure CBD, Isolate, Hemp Oil, THC-free CBD Distillate and Crude CBD Oil; (2) Partnerships with local farmers to grow farm bill compliant hemp biomass; (3) Partnerships with extract facilities across the U.S. who manufacture hemp-based ingredients to meet the specific needs financial products in form of asset-backed loans, business property mortgages and other financial products to qualified individuals/businesses in the legal-CBD businesses; and (4) professional services including top-level financial reporting, Accounting, CSE Reporting, Business Valuation, Mergers & Acquisitions, GAAP/ IFRS Conversion, Pre IPO/RTO Prep, Section 280E Tax, and Biological Assets Valuation to CBD/Hemp businesses and investors in California at first, then to those within the other states that has legalized cannabis.

The CBD market in the US is very fragmented, lack established process control and protocols, and is without formulations standardization. KCBDZ is stepping into this space to standardize and reorganize this market, establish process control (benchmarks and protocols), and create formulation standards for the industry. CBDZ seeks to control the production and distribution of verities of consumer cannabidiol (CBD) formulation under private brands in the United States. CBDZ’s goal is to bring standardization to the CBD industry, the same way that John D Rockefeller’s Standard Oil brought standardization to crude refining in the United States in the nineteenth century.

Our process standardization would entail steps that include (a) ethanol extraction system, (b) winterization to remove fats; (c) multiple rounds of rotary evaporation are used to remove plant material and other unnecessary components; (d) extract decarboxylation to transform into a crystalline structure with a proprietary post-processing technique; and (e) extract testing by third-party laboratories, packaging, and readiness for shipment.

Opportunities for Rollup and Consolidation

CBDZ (WWW.CBDXFUND.COM) has identified and intends to rollup 10 CBD operations with $54 million in annual revenue. These rollup will IPO on the NASDAQ or NYSE and Canadian Securities Exchange (CSE).

CBDZ want to raise $125 million via Regulation A+ ($50 million) and Regulation D 506 (c) ($75 million) for rollup is the Cannabis/hemp/CBD industry.

We need to raise $50 million to acquire ≥10 CBD operations which we’ll rollup into our holding company and IPO on the NASDAQ or New York Stock Exchange.All our targeted acquisitions are profitable operations.We plan to keep 50% of the profits for future growth, and pay 50% back to our investors as dividends.

Value Proposition:

  • CBDZ provide investors with opportunity to invest in the cannabis industry at the ground floor.For example, if an investor wants to invest in the publicly traded cannabis businesses on the stock market today, the investor would be paying $131-$215 price to sale multiples.
  • Investing with us would give the investors a better deal because we’ll be acquiring cannabis/hemp/cbd businesses at close to 2:1 investment to revenue.For example, with the 10 CBD operations identified, we’ll be buying at less than $2.00 for every $1.00 of revenue.

Value-adding Processes

Our proforma financial projection showed that this rollup could be worth $4.6 billion on the stock exchange once CBDZ have finished rollup and consolidation of all the 10 CBD operations and hemp cultivation facilities with $54 million in revenue. This valuation is based on the weighted average multiple of X-sales and X-net profit of cannabis businesses currently trading on the exchanges.

Important Development

In pursuit our goal of getting listed or up-listed on the Nasdaq within the next 36 months, we acquired voting control of Kid Castle Educational Corporation (OTC PINK: KDCE) on October 21, 2019. Kid Castle is traded on the OTC pinksheet with the ticker symbol KDCE. See. https://finance.yahoo.com/quote/KDCE?p=KDCE&.tsrc=fin-srchSee also. https://seekingalpha.com/symbol/KDCE?s=kdce We plan to clean the shell and bring it current with all the reporting requirements in other to qualify for uplisting to the Nasdaq.

KPIs

$54,000,000 Sales
31.48% ROI
Cash Flow Positive

Pitch Deck

Traction

  • We are currently reviewing transfer agents to see who is most likely to help our objectives of becoming Nasdaq-listed 36 months.

    May, 2019
  • Good news. Our Reg A+ Tier 2 Offering Circular has been qualified by the US Securities and Exchange Commission (SEC) on April 16, 2019.

    April, 2019
  • CBDZ is negotiating with the largest Indian reservation in Portland, Oregon to secure a large land to grow hemp and open CBD extraction

    December, 2018
  • As part of this agreement, CBDZ would acquire all prior invention of the scientist including all cannabis/hemp based formulations.

    December, 2018
  • CBDZ is in the middle of negotiating employment agreement with certain CBD/THC scientist as a Chief Scientific Officer, to join our team.

    December, 2018
  • Finalized Regulation D 506(c) offering for its Secured Convertible Note paying 8% annual interest. A $1,000 Note is convertible into 80

    December, 2018
  • Filed Regulation A+ with the U.S. Securities and Exchange Commission (SEC).

    December, 2018
  • Company was formed

    May, 2014
  • We acquired voting control of Kid Castle Educational Corporation (OTCPINK: KDCE) on October 21, 2019.

    October, 2019
Loading...